Page last updated: 2024-09-05

ly 300164 and ALS - Amyotrophic Lateral Sclerosis

ly 300164 has been researched along with ALS - Amyotrophic Lateral Sclerosis in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bendotti, C; Engelhardt, JI; Obál, I; Paizs, M; Patai, R; Siklós, L; Tortarolo, M	1
Bjerke, JS; Chappell, AS; Chaudhry, V; Clawson, L; Haas, L; Pascuzzi, RM; Rothstein, JD; Shefner, J; Tamura, R	1
Klaassen, H; Robberecht, W; Van Den Bosch, L; Van Houtte, E; Vandenberghe, W	1

Trials

1 trial(s) available for ly 300164 and ALS - Amyotrophic Lateral Sclerosis

Article	Year
A phase II trial of talampanel in subjects with amyotrophic lateral sclerosis. Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases, 2010, May-03, Volume: 11, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amyotrophic Lateral Sclerosis; Benzodiazepines; Disability Evaluation; Double-Blind Method; Electrocardiography; Excitatory Amino Acid Antagonists; Female; Humans; Male; Middle Aged; Muscle Strength; Muscle, Skeletal; Neurologic Examination; Time Factors; Treatment Outcome; Young Adult	2010

Article

Year

A phase II trial of talampanel in subjects with amyotrophic lateral sclerosis.

Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases, 2010, May-03, Volume: 11, Issue:3

Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amyotrophic Lateral Sclerosis; Benzodiazepines; Disability Evaluation; Double-Blind Method; Electrocardiography; Excitatory Amino Acid Antagonists; Female; Humans; Male; Middle Aged; Muscle Strength; Muscle, Skeletal; Neurologic Examination; Time Factors; Treatment Outcome; Young Adult

2010

Other Studies

2 other study(ies) available for ly 300164 and ALS - Amyotrophic Lateral Sclerosis

Article	Year
Presymptomatically applied AMPA receptor antagonist prevents calcium increase in vulnerable type of motor axon terminals of mice modeling amyotrophic lateral sclerosis. Biochimica et biophysica acta. Molecular basis of disease, 2017, Volume: 1863, Issue:7 Topics: Amyotrophic Lateral Sclerosis; Animals; Benzodiazepines; Calcium; Calcium Signaling; Disease Models, Animal; Humans; Mice; Mice, Transgenic; Presynaptic Terminals; Receptors, AMPA; Superoxide Dismutase	2017
Ca(2+)-permeable AMPA receptors and selective vulnerability of motor neurons. Journal of the neurological sciences, 2000, Nov-01, Volume: 180, Issue:1-2 Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Amyotrophic Lateral Sclerosis; Animals; Benzodiazepines; Calcium Channels; Cell Survival; Cells, Cultured; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Kainic Acid; Motor Neurons; Neurotoxins; Nifedipine; Posterior Horn Cells; Rats; Rats, Wistar; Receptors, AMPA; Spider Venoms	2000

Article

Year

Presymptomatically applied AMPA receptor antagonist prevents calcium increase in vulnerable type of motor axon terminals of mice modeling amyotrophic lateral sclerosis.

Biochimica et biophysica acta. Molecular basis of disease, 2017, Volume: 1863, Issue:7

Topics: Amyotrophic Lateral Sclerosis; Animals; Benzodiazepines; Calcium; Calcium Signaling; Disease Models, Animal; Humans; Mice; Mice, Transgenic; Presynaptic Terminals; Receptors, AMPA; Superoxide Dismutase

2017

Ca(2+)-permeable AMPA receptors and selective vulnerability of motor neurons.

Journal of the neurological sciences, 2000, Nov-01, Volume: 180, Issue:1-2

Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Amyotrophic Lateral Sclerosis; Animals; Benzodiazepines; Calcium Channels; Cell Survival; Cells, Cultured; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Kainic Acid; Motor Neurons; Neurotoxins; Nifedipine; Posterior Horn Cells; Rats; Rats, Wistar; Receptors, AMPA; Spider Venoms

2000